Birdi Figure 1 (Avt02 Unbranded Birdi 1)
Dosage regimen: 40mg every other week - Placebo.*
Adalimumab-ryvk Kit
Product Images NDC 51759-310
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 50 technical images submitted to the FDA as part of the official labeling for Adalimumab-ryvk (NDC 51759-310). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 6 (Avt02 Unbranded Birdi 10)
Figure 7 (Avt02 Unbranded Birdi 11)
Figure 8 (Avt02 Unbranded Birdi 12)
Figure 9 (Avt02 Unbranded Birdi 13)
Figure 10 (Avt02 Unbranded Birdi 14)
Figure 11 (Avt02 Unbranded Birdi 15)
Figure 12 (Avt02 Unbranded Birdi 16)
Figure 13 (Avt02 Unbranded Birdi 17)
Figure 14 (Avt02 Unbranded Birdi 18)
Figure 15 (Avt02 Unbranded Birdi 19)
Birdi Figure 2 (Avt02 Unbranded Birdi 2)
This text seems to be a comparison between placebo (n=107) and Adalimumab (n=208) in terms of % ASAS 20 Response over a period of Time (Weeks). The ASAS 20 Response is shown to be 83% for the placebo group and not directly mentioned for Adalimumab. The graph or data represented in the text seems to indicate the response rates over a certain period of time for the two groups.*
Birdi 16 (Avt02 Unbranded Birdi 20)
Birdi 17 (Avt02 Unbranded Birdi 21)
Birdi 18 (Avt02 Unbranded Birdi 22)
Birdi 19 (Avt02 Unbranded Birdi 23)
Birdi 20 (Avt02 Unbranded Birdi 24)
Birdi 21 (Avt02 Unbranded Birdi 25)
Birdi 22 (Avt02 Unbranded Birdi 26)
Birdi 23 (Avt02 Unbranded Birdi 27)
Birdi 24 (Avt02 Unbranded Birdi 28)
Birdi 25 (Avt02 Unbranded Birdi 29)
Birdi Figure 3 (Avt02 Unbranded Birdi 3)
Birdi 26 (Avt02 Unbranded Birdi 30)
Birdi 27 (Avt02 Unbranded Birdi 31)
Birdi 28 (Avt02 Unbranded Birdi 32)
Birdi 29 (Avt02 Unbranded Birdi 33)
Birdi 30 (Avt02 Unbranded Birdi 34)
Pfs Image 1 (Avt02 Unbranded Birdi 35)
This text does not provide enough context to generate a description.*
Pfs Image Figure A (Avt02 Unbranded Birdi 36)
Pfs Image Figure B (Avt02 Unbranded Birdi 37)
Pfs Image 34 (Avt02 Unbranded Birdi 38)
Pfs Image 34 (Avt02 Unbranded Birdi 39)
Birdi Figure 4 (Avt02 Unbranded Birdi 4)
Pfs Image 35 (Avt02 Unbranded Birdi 40)
Pfs Image 37 (Avt02 Unbranded Birdi 41)
Pfs Image 38 (Avt02 Unbranded Birdi 42)
Pfs Image 39 (Avt02 Unbranded Birdi 43)
Pfs Figure 40 (Avt02 Unbranded Birdi 44)
Pfs Image Figure J (Avt02 Unbranded Birdi 45)
Pfs Figure 42 (Avt02 Unbranded Birdi 46)
Pfs Figure L (Avt02 Unbranded Birdi 47)
Pfs Image 44 (Avt02 Unbranded Birdi 48)
40 mg 2 Pk Ai Aw (Avt02 Unbranded Birdi 49)
This is a description of medical supplies including 180mm and 100mm autoclaves for subcutaneous injections. The text mentions single-dose autanectors for subcutaneous use only.*
Birdi Ai 1 Aw (Avt02 Unbranded Birdi 5)
This appears to be a description of a product with a clear cap, a gray body, a neeche rip area, a sioeve, a plunger, and a stopper. The specific product is not provided in the text.*
80 mg 1 Ai Aw (Avt02 Unbranded Birdi 50)
This text provides information about an injection that contains 80 mg/0.8 mL of medication for subcutaneous use only. It appears to be a single-dose autoinjector with a needle length of 180mm.*
Figure 2 Ai (Avt02 Unbranded Birdi 6)
Figure 3 (Avt02 Unbranded Birdi 7)
Figure 4 (Avt02 Unbranded Birdi 8)
Figure 5 (Avt02 Unbranded Birdi 9)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
